PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 10, 2025Laboratory Medicine

Platelet parameters and their role in myeloproliferative neoplasms, immune-mediated thrombocytopenia, and myelodysplastic syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSoon Hee Chang

Discussion

Loading...

Member takes

Overview

Observational analysis reveals significant differences in platelet parameters among patients with myeloproliferative neoplasms and immune-mediated thrombocytopenia, indicating platelet activation.

Key Points

  • Platelet parameters showed significant differences in patients with myeloproliferative neoplasms compared to healthy controls, indicating high platelet activation.
  • Statistically significant differences in mean platelet volume, plateletcrit, and mean platelet component were observed among the disorders studied.
  • A total of 418 patients were enrolled, with notable distinctions in platelet parameters across the three hematologic conditions compared to healthy controls.
  • The findings suggest that platelet parameters can serve as useful biomarkers for differentiating diseases characterized by platelet dysfunction.

Cite This Study

Soon Hee Chang (2025) studied this question.

synapsesocial.com/papers/68c1c64554b1d3bfb60f2853https://doi.org/10.1093/labmed/lmaf033
View Full Paper
Ask AI
Bookmark
Share